Neuroprotective Effects of the Nutraceutical Dehydrozingerone and Its C2-Symmetric Dimer in a Drosophila Model of Parkinson’s Disease
Biomolecules · 24.02.2024 · 14 (3) · 273
DOI: 10.3390/biom14030273 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 24.02.2024. Verfasst von Maria Dolores Setzu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, University of Cagliari, Monserrato, 09042 Cagliari, Italy. Hauptthemen laut MEDLINE: Parkinson Disease, Neuroprotective Agents, Persons with Disabilities, Motor Disorders. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Council, University of Cagliari, University of Cagliari, Italy.
Abstract (Originalsprache)
Parkinson’s disease (PD) is a neurodegenerative disorder characterized by the loss of dopaminergic neurons responsible for unintended or uncontrollable movements. Mutations in the leucine-rich repeat kinase 2 locus contribute to genetic forms of PD. The fruit fly Drosophila melanogaster carrying this mutation (LRRK2-Dm) is an in vivo model of PD that develops motor impairment and stands for an eligible non-mammalian paradigm to test novel therapeutic approaches. Dehydrozingerone (DHZ) is a natural phenolic compound isolated from ginger and presents anti-inflammatory, antioxidant and neuroprotective properties, making it a potential therapeutic target for PD. We administered DHZ and its C2-symmetric dimer (DHZ-DIM) at 0.5 and 1 mM for 14 and 21 days in the LRRK2-Dm, with the aim of assessing changes in rescuing motor behavior, brain dopaminergic neurons, mitochondria and synapses (T-bars). The shorter treatment with both molecules revealed efficacy at the higher dose, improving climbing behavior with a prevention of dopaminergic neuronal demise. After 21 days, a recovery of the motor disability, dopaminergic neuron loss, mitochondrial damage and T-bars failure was observed with the DHZ-DIM. Our data indicate that the DHZ-DIM exerts a more potent neuroprotective effect with respect to the monomer in LRRK2-Dm, prompting further investigation of these compounds in rodent models of PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, University of Cagliari, Monserrato, 09042 Cagliari, Italy.
- Unit of Cagliari, CNR-Institute of Translational Pharmacology, Pula, 09050 Cagliari, Italy.
- Unit of Sassari, CNR-Institute of Biomolecular Chemistry, 07100 Sassari, Italy.
ORCID-Profile: Davide Fabbri, Paola Carta, Andrea Diana, Maria Antonietta Dettori, Maria Antonietta Casu
Förderung
- National Research Council
- University of Cagliari
- University of Cagliari, Italy
- Institute of Biomolecular Chemistry, Unit of Sassari, Italy
Zitieren
APA
Setzu, M. D., Mocci, I., Fabbri, D., Carta, P., Muroni, P., Diana, A., Dettori, M. A., & Casu, M. A. (2024). Neuroprotective Effects of the Nutraceutical Dehydrozingerone and Its C2-Symmetric Dimer in a Drosophila Model of Parkinson’s Disease. Biomolecules, 14(3), 273. https://doi.org/10.3390/biom14030273
Vancouver
Setzu MD, Mocci I, Fabbri D, Carta P, Muroni P, Diana A, et al. Neuroprotective Effects of the Nutraceutical Dehydrozingerone and Its C2-Symmetric Dimer in a Drosophila Model of Parkinson’s Disease. Biomolecules. 2024;14(3):273. doi:10.3390/biom14030273
BibTeX
@article{Setzu2024,
author = {Setzu, Maria Dolores and Mocci, Ignazia and Fabbri, Davide and Carta, Paola and Muroni, Patrizia and Diana, Andrea and Dettori, Maria Antonietta and Casu, Maria Antonietta},
title = {Neuroprotective Effects of the Nutraceutical Dehydrozingerone and Its C2-Symmetric Dimer in a Drosophila Model of Parkinson’s Disease},
journal = {Biomolecules},
year = {2024},
volume = {14},
number = {3},
pages = {273},
doi = {10.3390/biom14030273}
}
EUVIMED